Immunic Inc (IMUX) stock has fallen -95.19% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives IMUX stock a score of 64 out of a possible 100.
That score is primarily influenced by a fundamental score of 89. In addition to the average rating from Wall Street analysts, IMUX stock has a mean target price of $50.00. This means analysts expect the stock to increase 201.93% over the next 12 months. IMUX’s score also includes a long-term technical score of 58. The short-term technical score for IMUX is 46.
What’s Happening with IMUX Stock Today
Immunic Inc (IMUX) stock is higher by 51.37% while the S&P 500 has fallen -0.06% as of 2:15 PM on Thursday, Jul 11. IMUX has gained $5.62 from the previous closing price of $10.94 on volume of 3,071,251 shares. Over the past year the S&P 500 is higher by 7.07% while IMUX has fallen -95.19%. IMUX lost -$39.16 per share in the over the last 12 months.